The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status
Clin Oncol (R Coll Radiol)
.
2024 Feb;36(2):128-129.
doi: 10.1016/j.clon.2023.12.001.
Epub 2023 Dec 10.
Authors
M Shah
1
,
V Noronha
1
,
V Patil
1
,
N Menon
1
,
A K Singh
1
,
A Shah
1
,
P Kumar
1
,
O Roychoudhary
2
,
Z Peelay
1
,
A Janu
3
,
N Purandare
4
,
N Chakrabarty
3
,
V Patil
3
,
R Kaushal
5
,
O Shetty
6
,
T Pai
6
,
P Chandrani
7
,
A Chougule
6
,
K Prabhash
1
Affiliations
1
Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
2
Biostatistics, Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
3
Department of Radiodiagnosis, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
4
Department of Nuclear Medicine, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
5
Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
6
Department of Molecular Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
7
Department of Medical Oncology Molecular Laboratory, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, Maharashtra, India.
PMID:
38097463
DOI:
10.1016/j.clon.2023.12.001
No abstract available
Publication types
Letter
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Non-Small-Cell Lung* / drug therapy
Group Processes
Humans
Lung Neoplasms* / drug therapy